Company Profile

BRILLIANT PHARMACEUTICAL CO.,LTD. CHENGDU
Year Established : 2007
Total Number of Staff : more than 1000
Main Competitive Advantages : Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Buyers' Specifications Accepted,Reputation,Quality Service
  • Contact Person :
  • Fax:

Chengdu Brilliant pharmaceutical group was founded in 2007, is a driven by high-tech  Api&drug interity research and development, commercial production and sales enterprises more than 5000 employees , in the top enterprises list of the national pharmaceutical industry ,  in 2003 owned "Chengdu high-tech enterprise postdoctoral research station".In 2011, was named in sichuan province, as Chengdu "enterprise technology center", "national high-tech enterprise", one of the famous domestic pharmaceutical enterprises. In 2019 is listed as the national drug firms declared in  new drug registration TOP10 list, ranked in the southwest declaration for quantity. The main varieties include: anti - inflammatory, cardiovascular, gynecological, neurologic, urinary, digestive 、contrast media and other fields.

After years of rapid development, Brilliant pharma group  owns many subsidiaries, two of the raw material (API)  production base, three preparations production base, all base passed  the national cGMP certification, the latest production base complys with high international standard , inspected  in 2017 by the EU and PMDA .10 years ago our drug research institute research center built up,  we invested hundreds of millions of dollars a year in RD,  The research center has the national "thousand talents program", Sichuan "hundred people plan", and the world first-class drug research and development experts. Currently approval of above three kinds of new drugs more than eighty varieties, with many countries designated production varieties and exclusive production varieties, has gradually formed leading research and development ability, large dosage forms and varieties, perfect marketing network .The group has completed its development goals for the past 10 years, and is now following the country's 13th five-year plan for the next five-year development plan.

PharmaSources Customer Service